Ali Jazayeri

Ali Jazayeri currently serves as an Operating Partner at SV Health Investors since January 2025. Prior to this role, Ali was the Chief Scientific Officer at OMass Therapeutics from October 2018 to January 2025. Earlier experience includes positions at Heptares Therapeutics, where Ali held various roles including Chief Technology Officer, Head of Protein Engineering, and Molecular Biology Group Leader from October 2007 to September 2018. Ali also worked as a Post-doc scientist at Cancer Research UK Clare Hall, and as a Scientist at KuDOS, focusing on DNA damage response pathways. Ali earned a PhD in Molecular Biology from the University of Cambridge and a BSc in Genetics from The University of Manchester.